Based on the available information, a key GSK meningitis vaccine is Bexsero, which targets Meningococcal group B.
Bexsero is a vaccine developed to protect against Meningococcal group B disease. Here's a breakdown:
- Type: It's a Meningococcal group B Vaccine.
- Composition: Bexsero contains four components derived from the surface of the Neisseria meningitidis group B bacteria.
- Target Group: It's administered to individuals aged 2 months and older.
- Purpose: The vaccine helps protect against diseases caused by the Neisseria meningitidis group B bacteria.
